Prevalence of and Risk Factors for Medication Nonadherence in Patients With Schizophrenia
A Comprehensive Review of Recent Literature
Bibliographic Data
| ID | 23345327 |
|---|---|
| Authors | Jonathan P Lacro (0000-0003-0259-9072, VA San Diego Healthcare System), Laura B Dunn (0000-0001-5669-6244, California Department of Education), Christian R Dolder (California Department of Education), Susan G Leckband (0000-0001-8748-5220, VA San Diego Healthcare System), Dilip V Jeste (0000-0002-1161-7351, California Department of Education) |
| Year | 2002 |
| Volume | 63 |
| Issue | 10 |
| Pages | 892-909 |
| Publication date | 2002-10-15 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | The Journal of Clinical Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 0160-6689 • E-ISSN: 1534-8628 |
| Publisher | Physicians Postgraduate Press, Inc (PUBLISHER) |
| DOI | 10.4088/jcp.v63n1007 |
| PMID | 12416599 |
| OpenAlex | W2070893229 |
| Language | EN |
| Citations received | 67 |
| References cited | 9 |
OBJECTIVE: Nonadherence to prescribed antipsychotic medications places patients with schizophrenia at a greatly increased risk of illness exacerbation and rehospitalization. Identification of risk factors for nonadherence is an initial step toward designing effective interventions. This article reviews recent literature on the prevalence of and risk factors for medication nonadherence in patients with schizophrenia. DATA SOURCES: We searched the MEDLINE/HealthSTAR and PsycINFO databases using combinations of the keywords risk factor(s), adherence, compliance, antipsychotic, neuroleptic, schizophrenia, and psychosis for articles published since 1980 that identified risk factors for medication nonadherence in schizophrenia patients. We included reports that (1) were published in English and (2) specifically examined risk factors for medication nonadherence. Thirty-nine articles met our selection criteria. DATA SYNTHESIS: Among the 10 reports that met a strict set of study inclusion criteria, we found a mean rate of nonadherence of 41.2%; the 5 reports that met a stricter set of inclusion criteria had a mean nonadherence rate of 49.5%. In the 39 articles reviewed, factors most consistently associated with nonadherence included poor insight, negative attitude or subjective response toward medication, previous nonadherence, substance abuse, shorter illness duration, inadequate discharge planning or aftercare environment, and poorer therapeutic alliance. Findings regarding an association between adherence and medication type were inconclusive, although few studies explored this relationship. Other factors such as age, gender, ethnicity, marital status, education level, neurocognitive impairment, severity of psychotic symptoms, severity of medication side effects, higher antipsychotic dose, presence of mood symptoms, route of medication administration, and family involvement were not found to be consistent predictors of nonadherence. Limitations of the published literature are discussed. CONCLUSION: Efforts to improve medication adherence in patients with schizophrenia should target relevant risk factors.
Antipsychotic · CINAHL · MEDLINE · Psychiatry · Psychological intervention · PsycINFO · Risk factor · Schizophrenia (object-oriented programming) · Clinical Psychology · Healthcare Decision-Making and Restraints · Internal Medicine · Medication Adherence and Compliance · Medicine · Schizophrenia research and treatment
From Wish to Reality
Rating Opportunity for Long-Acting Injectable Antipsychotic Initiation Index (Rolin)
Tolerability profile of paliperidone palmitate formulations
Part II
Clinic Appointment Attendance in Adults with Serious Mental Illness and Diabetes
Toward Understanding the Insight Paradox
Adherence to Medication
Substance Abuse and Psychiatric Disorders in HIV-Positive Patients
Reducing the Emotionality of Auditory Hallucination Memories in Patients Suffering From Auditory Hallucinations
Treatment continuation and factors associated with discontinuation with 3-month paliperidone palmitate in patients with schizophrenia
From contact coverage to effective coverage of community care for patients with severe mental disorders
New Dutch Legislation and Preventive Coercive Home Health Care for Excessive Alcohol Consumers
Identifying Modifiable Risk Factors for Relapse in Patients With Schizophrenia in China
Right to Appeal, Non-Treatment, and Violence Among Forensic and Civil Inpatients Awaiting Incapacity Appeal Decisions in Ontario
A psychological flexibility model of medication adherence in psychotic-spectrum disorders
Interrupting the Cycle
Medication adherence, treatment satisfaction, and patient–doctor relationship in patients with mood disorders at a Saudi tertiary care hospital
Effectiveness of Paliperidone Palmitate in Reducing Acute Psychiatric Service Use for Patients Suffering from Psychosis—A Retrospective Mirror-Image Study
Chronic haloperidol administration downregulates select BDNF transcript and protein levels in the dorsolateral prefrontal cortex of rhesus monkeys
Levels of Recovery Scale (Lors)
Ultrasonographic assessment of thenar muscles for diagnosing sarcopenic obesity in patients with schizophrenia
Reduction of Involuntary Admissions in Patients With Severe Psychotic Disorders Treated in the Access Integrated Care Model Including Therapeutic Assertive Community Treatment
Family psychoeducation in schizophrenia and schizophrenia related disorder, treatment compliance, and suicidal risk reduction
Lifetime Cannabis Use Is Not Associated With Negative Beliefs About Medication in Patients With First Treatment Psychosis
Medication Adherence in a Cross-Diagnostic Sample of Patients From the Affective-to-Psychotic Spectrum
Do Community Free-Medication Service Policy Improve Patient Medication Adherence? A Cross-Sectional Study of Patients With Severe Mental Disorders in Beijing Community
Mental health service satisfaction among adults with mental illness attending a psychiatric outpatient clinic
Feasibility of a Virtual Reality-Based Psychoeducational Tool (VRight) for Depressive Patients
Medication nonadherence
Poor adherence to antipsychotics amongst schizophrenia patients in Nigeria
Description of the inpatient population and care received at a psychiatric unit in Lilongwe, Malawi
Informed consent is a bit of a joke to me’
Detecting Serious Mental Illness Among Substance Abusers
Part I
Client Outreach in Los Angeles County’s Assisted Outpatient Treatment Program
Addressing challenges in prescribing for vulnerable unsheltered homeless populations with mental illness
Schizophrenia interventions in Vietnam
Involved, inputting or informing
Religiosity and treatment adherence among out-patients with schizophrenia
Differences in Adherence to Antihypertensive Medication Regimens According to Psychiatric Diagnosis
Non-pharmacological treatments for schizophrenia in Southeast Europe
Focusing on the adult attachment style in schizophrenia in community mental health centres
Correlating cognitive functions to symptom domains and insight in Egyptian patients with schizophrenia
MHealth for schizophrenia spectrum disorders management
Adherence therapy following acute exacerbation of schizophrenia
Promoting Treatment Adherence in Assertive Community Treatment
Religious Beliefs and Their Relevance for Treatment Adherence in Mental Illness
Insight into illness and adherence to psychotropic medications are separately associated with violence severity in a forensic sample
Family Therapy for Schizophrenia in the South African Context
A Pilot Test of a Peer Navigator Intervention for Improving the Health of Individuals with Serious Mental Illness
Patient Voices
Perception of Community Pharmacists in Malaysia About Mental Healthcare and Barriers to Providing Pharmaceutical Care Services to Patients with Mental Disorders
Comparison of Immigrant and Native-Born Population Adherence to Antipsychotic Treatment in a Spanish Health Region
Predictors of Medication Non-adherence in Bulgarian Outpatients with Schizophrenia
Routine Outcomes Monitoring to Support Improving Care for Schizophrenia
Reasons for Nonadherence to Psychiatric Medication and Cardiovascular Risk Factors Treatment Among Latino Bipolar Disorder Patients Living in Puerto Rico
Characteristics of Homeless Adults with Serious Mental Illness Served by a State Mental Health Transitional Shelter
Antipsychotics and Medical Comorbidity
Recovery from Schizophrenia
Family Contact and the Management of Medication Non-adherence in Schizophrenia
Treatment for Comorbid Mental Health Disorders Among Patients Treated for Opioid Disorder
Shelter-based Convalescence for Homeless Adults
Mental health is biological health
Consumers' and practitioners' perspectives on the antipsychotic induced metabolic syndrome and challenges in metabolic monitoring to patient prescribed second generation antipsychotics in severe mental illness
Insight Development in Schizophrenia
Sharing decisions in consultations involving anti-psychotic medication
Antipsychotic medication, sedation and mental clouding
The Global Assessment Scale
What is Motivational Interviewing?
A Diagnostic Interview
The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia
“Mini-mental state”
Non-Compliance With Treatment in Patients Suffering From Schizophrenia
The Brief Psychiatric Rating Scale
Effectiveness of Interventions to Improve Patient Compliance
Utility of the health belief model in examining medication compliance among psychiatric outpatients
| Unique citing works | 67 |
|---|---|
| Citations per year | 3,19 |
| Citation span | 2005 - 2026 (22) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 62 |